TIMI 11A

OBJECTIVE: To compare the safety and tolerability of two weight-adjusted regimens of subcutaneous injections of enoxaparin among patients presenting with unstable angina or non-Q-wave myocardial infarction.

View/Download
_______________________________________________________________________________

1. Dose-ranging trial of enoxaparin for unstable angina: results of TIMI 11A. The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators. J Am Coll Cardiol 1997;29:1474-82.
   | Abstract | Request Reprints |
   

2. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. Morrow DA, Rifai N, Antman EM, et al. J Am Coll Cardiol 1998;31:1460-5.
   | Abstract | Request Reprints |
   

3. Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy. Antman EM, Sacks DB, Rifai N, McCabe CH, Cannon CP, Braunwald E. J Am Coll Cardiol 1998;31:326-30.
   | Abstract | Request Reprints |

   
   
4. Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. Morrow DA, Rifai N, Antman EM, et al. J Am Coll Cardiol 2000;35:358-62.
   | Abstract | Request Reprints |